DK82177A - Fremgangsmade til fremstilling af aminoglycosidderivater mellemprodukter til anvendelse ved denne fremgangsmade og fremgangsmade til deres fresmtilling - Google Patents

Fremgangsmade til fremstilling af aminoglycosidderivater mellemprodukter til anvendelse ved denne fremgangsmade og fremgangsmade til deres fresmtilling

Info

Publication number
DK82177A
DK82177A DK82177A DK82177A DK82177A DK 82177 A DK82177 A DK 82177A DK 82177 A DK82177 A DK 82177A DK 82177 A DK82177 A DK 82177A DK 82177 A DK82177 A DK 82177A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
aminoglycoside derivatives
intermediate uses
derivatives intermediate
Prior art date
Application number
DK82177A
Other languages
Danish (da)
English (en)
Inventor
B C Ross
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK82177A publication Critical patent/DK82177A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/081,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D265/101,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen atoms directly attached to ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK82177A 1976-02-25 1977-02-24 Fremgangsmade til fremstilling af aminoglycosidderivater mellemprodukter til anvendelse ved denne fremgangsmade og fremgangsmade til deres fresmtilling DK82177A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7529/76A GB1529243A (en) 1976-02-25 1976-02-25 Process for the preparation of aminoglycoside derivatives and cyclic urethane intermediates for use therein

Publications (1)

Publication Number Publication Date
DK82177A true DK82177A (da) 1977-08-26

Family

ID=9834870

Family Applications (1)

Application Number Title Priority Date Filing Date
DK82177A DK82177A (da) 1976-02-25 1977-02-24 Fremgangsmade til fremstilling af aminoglycosidderivater mellemprodukter til anvendelse ved denne fremgangsmade og fremgangsmade til deres fresmtilling

Country Status (26)

Country Link
US (1) US4107435A (de)
JP (1) JPS52111545A (de)
AR (1) AR215616A1 (de)
AT (1) AT348123B (de)
BE (1) BE851777A (de)
CA (1) CA1071624A (de)
CH (1) CH618706A5 (de)
CS (2) CS195714B2 (de)
DD (2) DD135200A5 (de)
DE (1) DE2708008C3 (de)
DK (1) DK82177A (de)
EG (1) EG12650A (de)
ES (1) ES456304A1 (de)
FI (1) FI770568A (de)
FR (2) FR2351109A1 (de)
GB (1) GB1529243A (de)
GR (1) GR66424B (de)
HU (1) HU179565B (de)
IE (1) IE44885B1 (de)
LU (1) LU76829A1 (de)
NL (2) NL166265C (de)
PL (2) PL102193B1 (de)
PT (1) PT66229B (de)
RO (1) RO76081A (de)
SE (1) SE7702066L (de)
SU (1) SU659092A3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5461151A (en) * 1977-10-25 1979-05-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4327087A (en) * 1978-01-16 1982-04-27 Schering Corporation Stabilized Netilmicin formulations
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
JPS5538345A (en) * 1978-09-11 1980-03-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4226980A (en) * 1978-12-07 1980-10-07 Abbott Laboratories Novel derivatives of fortimicin B and process for preparing same
DE2924659A1 (de) * 1979-06-19 1981-01-22 Bayer Ag Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel
DE3000841A1 (de) * 1980-01-11 1981-07-16 Bayer Ag, 5090 Leverkusen Isolierung und reinigung von aminoglycosid-antibiotiaka
DE3101376A1 (de) * 1981-01-17 1982-09-02 Bayer Ag, 5090 Leverkusen Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
WO2009117036A2 (en) * 2007-12-21 2009-09-24 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
US10766970B2 (en) 2016-07-01 2020-09-08 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same
WO2018005964A1 (en) * 2016-07-01 2018-01-04 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2399118A (en) * 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
SE324857B (de) * 1962-04-03 1970-06-15 Rit Rech Ind Therapeut

Also Published As

Publication number Publication date
CH618706A5 (de) 1980-08-15
PT66229B (en) 1978-07-17
LU76829A1 (de) 1978-10-18
FR2351109A1 (fr) 1977-12-09
NL7901693A (nl) 1979-07-31
DD130150A5 (de) 1978-03-08
CA1071624A (en) 1980-02-12
DE2708008A1 (de) 1977-09-01
FR2351127A1 (fr) 1977-12-09
DD135200A5 (de) 1979-04-18
DE2708008B2 (de) 1981-07-02
AT348123B (de) 1979-01-25
FI770568A (de) 1977-08-26
NL166265C (nl) 1981-07-15
EG12650A (en) 1979-06-30
ATA116777A (de) 1978-06-15
HU179565B (en) 1982-11-29
FR2351109B1 (de) 1981-07-24
DE2708008C3 (de) 1982-04-22
SU659092A3 (en) 1979-04-25
PT66229A (en) 1977-03-01
NL7701980A (nl) 1977-08-29
CS195715B2 (en) 1980-02-29
AR215616A1 (es) 1979-10-31
PL103737B1 (pl) 1979-07-31
GB1529243A (en) 1978-10-18
GR66424B (de) 1981-03-20
RO76081A (ro) 1981-08-17
FR2351127B1 (de) 1981-06-12
SE7702066L (sv) 1977-08-26
PL102193B1 (pl) 1979-03-31
CS195714B2 (en) 1980-02-29
IE44885L (en) 1977-08-25
NL166265B (nl) 1981-02-16
US4107435A (en) 1978-08-15
IE44885B1 (en) 1982-05-05
BE851777A (fr) 1977-08-24
ES456304A1 (es) 1978-01-16
JPS52111545A (en) 1977-09-19

Similar Documents

Publication Publication Date Title
DK148751C (da) Fremgangsmaade til fremstilling af cyclosporinderivater
DK63178A (da) Fremgangsmaade til fremstilling af pyrrodinderivater
DK536178A (da) Fremgangsmaade til fremstilling af stilbenderivater
DK142372C (da) Fremgangsmaade til fremstilling af androstan-17-on-derivater
DK180878A (da) Fremgangsmaade til fremstilling af imidazoaziner og imidazodiaziner
DK82177A (da) Fremgangsmade til fremstilling af aminoglycosidderivater mellemprodukter til anvendelse ved denne fremgangsmade og fremgangsmade til deres fresmtilling
DK152732C (da) Fremgangsmaade til fremstilling af imidazodiazepinderivater
DK178677A (da) Fremgangsmade til fremstilling af adeninderivater
DK345977A (da) G rifamycinforbindelser og fremgangsmaade til deres fremstillin
DK30578A (da) Fremgangsmaade til fremstilling af aminoalkoxyphenylderivater
DK312878A (da) Fremgangsmaade til fremstilling af indolderivater
DK577377A (da) Fremgangsmaade til fremstilling af 7ksi(alkoxycarbonyl)-6ksi-alkyl/halogen-17-hydroxy3-oxo-17alfa-pregn-4-en-21-carboxylsyre-gammalactoner og tilsvarende 21-carboxylsyrer deres salte og estere
DK462976A (da) Fremgangsmade til fremstilling af snacks og forblanding til anvendelse ved denne fremgangsmade
DK50778A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
DK522180A (da) Fremgangsmaade til fremstilling af indolderivater
DK118177A (da) Fremgangsmade til fremstilling af isobutyramidderivater
DK182978A (da) Fremgangsmaade til fremstilling af 1-n-(omegaamino-alfa-hydroxyalkanoyl) kanamyciner
DK50878A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
DK300978A (da) Fremgangsmaade til fremstilling af indolderivater
DK246878A (da) Fremgangsmaade til fremstilling af acylderivater
DK3177A (da) Fremgangsmade til fremstilling af hydrazinderivater
DK214678A (da) Fremgangsmaade til fremstilling af benzazepinderivater
DK61778A (da) Fremgangsmaade til fremstilling af everninominderivater
DK417778A (da) Fremgangsmaade til fremstilling af thienobenzazepinderivater
DK105078A (da) Fremgangsmaade til fremstilling af isobutyramidderivater